Author
1 MIN READ
In this video interview, Brad Thompson discusses Oncolytics Biotech’s current advances in cancer therapy, future pipeline and the benefits of cross-listing in the US.
This content is provided by OTC Markets and did not involve IR Magazine journalists.
Building trust and driving impact: Redefining investor relations in South East Asia Investor Relations in South East Asia is at a turning point. Regulatory fragmentation, macroeconomic volatility and the growing importance of retail investors require IROs to strategically analyze and reform traditional practices. The ability to deliver transparent, dependable and…
In partnership with WHEN 8.00 am PT / 11.00 am ET / 4.00 pm GMT / 5.00 pm CET DURATION 45 minutes About the event Explore how IR teams can adapt to the rise of passive investing while effectively measuring and communicating their impact. As index funds and ETFs reshape…
Adapting to change in Greater China: IR strategies for a sustainable, digital and global era The investor relations landscape in Greater China is being reshaped by rapid technological advances, growing ESG expectations, tighter budgets and increasing geopolitical pressures. Digital tools such as automation and Artificial Intelligence (AI) are transforming how…
Stay informed on critical issues affecting IR teams, gain expert analysis of market trends, buy-side insights, career advice, and more.
Our new tool lets you benchmark your IR program against peers in your region and sector, uncover strengths, and identify areas for growth.
Packed with industry trends and insights that define best-in-class practices across key, practical, and timely aspects of an IRO’s role.
Powered by the world’s largest survey of the buy side, sell side, and IR professionals, discover data-driven insights on running a successful IR program.